2021
DOI: 10.2147/dmso.s302627
|View full text |Cite
|
Sign up to set email alerts
|

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus

Abstract: Purpose To assess the association of type 2 diabetes mellitus (T2DM) and insulin glargine treatment with bone mineral density (BMD) in Chinese people. Methods This retrospective study included 50 subjects with T2DM: 25 received oral glucose-lowering medication (ORL group), and 25 received oral glucose-lowering medication in combination with insulin glargine injection (CGI group). Thirty non-diabetic control subjects were also included. BMD was measured at lumbar vertebr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
2

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(11 citation statements)
references
References 55 publications
1
5
2
Order By: Relevance
“…It is widely accepted that the risk of osteoporosis increases with the prolongation of the duration of DM disease. 20 BMD was reported to decrease with the prolongation of the duration of DM, which was supported by several previous studies. 21 Pathological changes accompanying diabetes are as follows: Decrease in bone collagen, decrease in maturation and transformation of bone matrix, and decrease in BMD value as a result of serum calcium deficiency.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…It is widely accepted that the risk of osteoporosis increases with the prolongation of the duration of DM disease. 20 BMD was reported to decrease with the prolongation of the duration of DM, which was supported by several previous studies. 21 Pathological changes accompanying diabetes are as follows: Decrease in bone collagen, decrease in maturation and transformation of bone matrix, and decrease in BMD value as a result of serum calcium deficiency.…”
Section: Discussionsupporting
confidence: 81%
“…It was stated that more studies are needed to determine whether there is a relationship between HBA1c and BMD or fracture risk. 20 No significant difference was found between HBA1c and t- scores in our study. It is widely accepted that the risk of osteoporosis increases with the prolongation of the duration of DM disease.…”
Section: Discussioncontrasting
confidence: 66%
“…[16] However, in human studies, data on the effect of insulin treatment on bone turnover markers and BMD are conflicting. [17,18] In addition to the known bone effects of diabetes, negative bone remodeling occurs due to hormonal changes caused by menopause, and the risk of osteoporosis and fracture increases rapidly in postmenopausal women. [19] Therefore, the effect of antidiabetic treatment on bone gains importance, especially in this patient group.…”
Section: Introductionmentioning
confidence: 99%
“…[ 16 ] However, in human studies, data on the effect of insulin treatment on bone turnover markers and BMD are conflicting. [ 17 , 18 ]…”
Section: Introductionmentioning
confidence: 99%
“…In another study, a positive association was observed between insulin resistance and osteoporosis, whereas a negative relationship was noted between β-cell function and osteoporosis among Taiwanese participants [5]. In patients with type 2 diabetes mellitus (T2DM), those receiving oral glucose-lowering medication and longacting insulin displayed higher spine bone mineral density (BMD) and serum calcium levels compared to those receiving oral glucose-lowering medication only [6]. Rats fed with a high-fat, high-carbohydrate diet displayed insulin resistance and a deterioration of the trabecular bone microstructure [7][8][9][10][11].…”
Section: Introductionmentioning
confidence: 99%